Real-time enrollment status for this acute myeloid leukemia (aml) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:18 PM UTC
| NCT Number | NCT05756777 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia (AML) |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | June 22, 2026 (Jun 22, 2026) |
As of August 28, 2026: Clinical trial NCT05756777 is currently recruiting participants. This phase1 study for acute myeloid leukemia (aml) is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05756777 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05756777 was last updated Jun 22, 2026 (June 22, 2026). HelloStudys verifies this status automatically.